• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有冠状动脉疾病的糖尿病患者中晚期糖基化终产物受体可溶性形式(sRAGE)的升高。

Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.

作者信息

Nakamura Kazuo, Yamagishi Sho-ichi, Adachi Hisashi, Kurita-Nakamura Yayoi, Matsui Takanori, Yoshida Takafumi, Sato Akira, Imaizumi Tsutomu

机构信息

Departments of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.

出版信息

Diabetes Metab Res Rev. 2007 Jul;23(5):368-71. doi: 10.1002/dmrr.690.

DOI:10.1002/dmrr.690
PMID:17024691
Abstract

BACKGROUND

Advanced glycation end products (AGEs)-receptor (RAGE) axis is implicated in diabetic vascular complication. Since a soluble form of RAGE (sRAGE) could be generated from the cleavage of cell surface RAGE in endothelial cells (ECs), serum sRAGE levels may be elevated in diabetes consequent to EC damage. In this study, we examined whether sRAGE levels were elevated in type 2 diabetic patients compared with non-diabetic healthy subjects.

METHODS

Serum sRAGE levels were examined in 75 Japanese type 2 diabetic patients (29 men and 46 women; mean age 66 +/- 11 years) and 75 age- and sex-matched non-diabetic healthy control subjects. We explored the association between sRAGE levels and coronary artery disease (CAD) in diabetic patients.

RESULTS

Serum sRAGE levels were significantly higher in diabetic patients than in non-diabetic subjects (965.3 +/- 544.2 vs 415 +/- 150.4 pg/mL, p < 0.001). In the univariate analysis, diastolic blood pressure (inversely), LDL cholesterol, triglycerides, HDL cholesterol, hemoglobin A(1c), and creatinine were significantly associated with sRAGE. After performing multivariate analyses, the presence of diabetes (p < 0.0001) was a sole independent determinant of sRAGE. Furthermore, there was a significant difference in sRAGE levels between diabetic patients with CAD and those without CAD (1680.6 +/- 891.1 vs 855.2 +/- 372.1 pg/mL, p < 0.001). Multiple stepwise regression analysis revealed that sRAGE and creatinine levels were independent determinants of CAD.

CONCLUSIONS

The present study demonstrated that serum sRAGE levels were significantly higher in type 2 diabetic patients than in non-diabetic subjects and positively associated with the presence of CAD.

摘要

背景

晚期糖基化终末产物(AGEs)-受体(RAGE)轴与糖尿病血管并发症有关。由于可溶性RAGE(sRAGE)可由内皮细胞(ECs)表面RAGE的裂解产生,糖尿病患者因EC损伤血清sRAGE水平可能升高。在本研究中,我们检测了2型糖尿病患者与非糖尿病健康受试者相比sRAGE水平是否升高。

方法

检测了75例日本2型糖尿病患者(29例男性和46例女性;平均年龄66±11岁)和75例年龄及性别匹配的非糖尿病健康对照者的血清sRAGE水平。我们探讨了糖尿病患者sRAGE水平与冠状动脉疾病(CAD)之间的关联。

结果

糖尿病患者血清sRAGE水平显著高于非糖尿病受试者(965.3±544.2 vs 415±150.4 pg/mL,p<0.001)。单因素分析中,舒张压(呈负相关)、低密度脂蛋白胆固醇、甘油三酯、高密度脂蛋白胆固醇、糖化血红蛋白A1c和肌酐与sRAGE显著相关。进行多因素分析后,糖尿病的存在(p<0.0001)是sRAGE的唯一独立决定因素。此外,有CAD的糖尿病患者与无CAD的糖尿病患者的sRAGE水平存在显著差异(1680.6±891.1 vs 855.2±372.1 pg/mL,p<0.001)。多元逐步回归分析显示,sRAGE和肌酐水平是CAD的独立决定因素。

结论

本研究表明,2型糖尿病患者血清sRAGE水平显著高于非糖尿病受试者,且与CAD的存在呈正相关。

相似文献

1
Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.患有冠状动脉疾病的糖尿病患者中晚期糖基化终产物受体可溶性形式(sRAGE)的升高。
Diabetes Metab Res Rev. 2007 Jul;23(5):368-71. doi: 10.1002/dmrr.690.
2
Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.2型糖尿病患者血清晚期糖基化终产物可溶性受体水平与循环晚期糖基化终产物之间的关联
Diabetologia. 2006 Nov;49(11):2756-62. doi: 10.1007/s00125-006-0394-1. Epub 2006 Sep 13.
3
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.循环晚期糖基化终产物可溶性受体与血糖控制及S100A12蛋白呈负相关。
J Clin Endocrinol Metab. 2006 Nov;91(11):4628-34. doi: 10.1210/jc.2005-2559. Epub 2006 Aug 22.
4
Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.在2型糖尿病患者中,血清晚期糖基化终末产物受体的可溶性形式(sRAGE)水平与循环中的晚期糖基化终末产物(AGEs)及血管细胞黏附分子-1的可溶性形式呈正相关。
Microvasc Res. 2008 May;76(1):52-6. doi: 10.1016/j.mvr.2007.09.004. Epub 2007 Oct 5.
5
Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.受体晚期糖基化终产物的表达增强与 2 型糖尿病患者循环中可溶性受体低表达有关。
Clin Sci (Lond). 2011 Jan;120(2):81-9. doi: 10.1042/CS20100256.
6
Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.血清晚期糖基化终末产物受体的可溶性形式(sRAGE)水平与2型糖尿病患者的炎症标志物相关。
Mol Med. 2007 Mar-Apr;13(3-4):185-9. doi: 10.2119/2006–00090.Nakamura.
7
Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function.血清 AGEs 与可溶性 RAGE 比值是内皮功能的预测指标。
Diabetes Care. 2015 Jan;38(1):119-25. doi: 10.2337/dc14-1435. Epub 2014 Oct 21.
8
Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.非糖尿病受试者血清晚期糖基化终产物水平与晚期糖基化终产物受体可溶性形式之间的正相关关系。
Metabolism. 2006 Sep;55(9):1227-31. doi: 10.1016/j.metabol.2006.05.007.
9
Soluble RAGE in type 2 diabetes: association with oxidative stress.2型糖尿病中的可溶性晚期糖基化终末产物受体:与氧化应激的关联
Free Radic Biol Med. 2007 Aug 15;43(4):511-8. doi: 10.1016/j.freeradbiomed.2007.03.015. Epub 2007 Mar 24.
10
Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.1型糖尿病患者晚期糖基化终末产物受体(RAGE)-374 T/A基因多态性及循环可溶性RAGE与肾病的相关性
Egypt J Immunol. 2009;16(1):95-106.

引用本文的文献

1
Soluble receptor for advanced glycation end products and its role in cardiovascular risk assessment in hyperglycemia - A study in North India.晚期糖基化终产物可溶性受体及其在高血糖心血管风险评估中的作用——印度北部的一项研究
J Family Med Prim Care. 2025 Apr;14(4):1325-1332. doi: 10.4103/jfmpc.jfmpc_1356_24. Epub 2025 Apr 25.
2
Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years.在6.3年的中位随访期间,1型糖尿病患者中可溶性晚期糖基化终末产物受体(sRAGE)与肥胖之间的关系。
Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06440-4.
3
Association between the soluble receptor for advanced glycation end products and diabetes mellitus: systematic review and meta-analysis.
可溶性晚期糖基化终产物受体与糖尿病的关系:系统评价和荟萃分析。
BMC Endocr Disord. 2024 Oct 30;24(1):232. doi: 10.1186/s12902-024-01759-2.
4
SGLT2i relieve proteinuria in diabetic nephropathy patients potentially by inhibiting renal oxidative stress rather than through AGEs pathway.钠-葡萄糖协同转运蛋白2抑制剂(SGLT2i)可能通过抑制肾脏氧化应激而非晚期糖基化终末产物(AGEs)途径来减轻糖尿病肾病患者的蛋白尿。
Diabetol Metab Syndr. 2024 Feb 16;16(1):46. doi: 10.1186/s13098-024-01280-5.
5
The Burden of Impaired Serum Albumin Antioxidant Properties and Glyco-Oxidation in Coronary Heart Disease Patients with and without Type 2 Diabetes Mellitus.血清白蛋白抗氧化特性受损及糖氧化在合并和未合并2型糖尿病的冠心病患者中的负担
Antioxidants (Basel). 2022 Jul 30;11(8):1501. doi: 10.3390/antiox11081501.
6
Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease.晚期糖基化终产物:一种令心血管疾病苦不堪言的甜蜜味道。
Int J Mol Sci. 2022 Feb 22;23(5):2404. doi: 10.3390/ijms23052404.
7
Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army Recruits.运动干预新兵队列四周后循环可溶性晚期糖基化终产物受体(sRAGE)及其配体 S100A8/A9 的差异调节
Biomolecules. 2021 Sep 13;11(9):1354. doi: 10.3390/biom11091354.
8
AGE-RAGE Stress and Coronary Artery Disease.年龄-晚期糖基化终末产物应激与冠状动脉疾病
Int J Angiol. 2021 Mar;30(1):4-14. doi: 10.1055/s-0040-1721813. Epub 2021 Jan 21.
9
The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes.使用晚期糖基化终末产物可溶性受体(sRAGE)作为疾病风险和不良结局的潜在生物标志物。
Redox Biol. 2021 Jun;42:101958. doi: 10.1016/j.redox.2021.101958. Epub 2021 Mar 29.
10
A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohorts.一种用于识别衰弱特征的强大机器学习框架:在四个欧洲老年队列中的巢式病例对照研究。
Geroscience. 2021 Jun;43(3):1317-1329. doi: 10.1007/s11357-021-00334-0. Epub 2021 Feb 18.